Skip to content

Insider · CIK 0001402017

Pellini Michael J

Reports to the SEC for 5 companies · ALISO VIEJO, CA

Transactions

50

Companies

5

Filings

9

CIK

0001402017

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-03-04ADPTAdaptive Biotechnologies CorpA Award—
2025-03-04ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award—
2025-02-21Singular Genomics Systems, Inc.D Disposition to Issuer—
2025-02-21Singular Genomics Systems, Inc.D Disposition to Issuer—
2025-02-21Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2025-02-21Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2025-02-21Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2025-02-21Singular Genomics Systems, Inc.Stock Option (Right to Buy)D Disposition to Issuer−$29.5K
2024-05-29Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award—
2024-03-04ADPTAdaptive Biotechnologies CorpA Award—
2024-03-04ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award—
2023-05-25Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award—
2023-03-06ADPTAdaptive Biotechnologies CorpA Award—
2023-03-06ADPTAdaptive Biotechnologies Corp · Stock Option (right to buy)A Award—
2022-10-15WGSGeneDx Holdings Corp.M Exercise/Conversion—
2022-10-15WGSGeneDx Holdings Corp. · Restricted Stock UnitM Exercise/Conversion—
2022-05-31Singular Genomics Systems, Inc.M Exercise/Conversion+$12.8K
2022-05-31Singular Genomics Systems, Inc.M Exercise/Conversion+$8,053.685
2022-05-31Singular Genomics Systems, Inc.M Exercise/Conversion+$37.8K
2022-05-31Singular Genomics Systems, Inc.G Gift—
2022-05-31Singular Genomics Systems, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2022-05-31Singular Genomics Systems, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2022-05-31Singular Genomics Systems, Inc.Stock Option (Right to Buy)M Exercise/Conversion—
2022-05-26Singular Genomics Systems, Inc.Stock Option (Right to Buy)A Award—
2022-05-18Singular Genomics Systems, Inc.P Purchase+$88.6K
2022-05-02WGSGeneDx Holdings Corp. · Stock OptionA Award—
2022-05-02WGSGeneDx Holdings Corp. · Stock Option (Right to Buy)A Award—
2022-05-02WGSGeneDx Holdings Corp. · Restricted Stock UnitA Award—
2022-04-27WGSGeneDx Holdings Corp.M Exercise/Conversion—
2022-04-27WGSGeneDx Holdings Corp. · Restricted Stock UnitM Exercise/Conversion—
2022-02-10Singular Genomics Systems, Inc.G Gift—
2022-01-26ADPTAdaptive Biotechnologies CorpA Award—
2022-01-26ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award—
2021-10-15WGSGeneDx Holdings Corp. · Employee Stock Option (Right to Buy)A Award—
2021-10-15WGSGeneDx Holdings Corp. · Employee Stock Option (Right to Buy)A Award—
2021-10-15WGSGeneDx Holdings Corp. · Restricted Stock UnitA Award—
2021-10-15WGSGeneDx Holdings Corp. · Restricted Stock UnitA Award—
2021-05-20Singular Genomics Systems, Inc.C Conversion—
2021-05-20Singular Genomics Systems, Inc.Series A Preferred StockC Conversion—
2021-03-01ADPTAdaptive Biotechnologies CorpM Exercise/Conversion+$131K
2021-03-01ADPTAdaptive Biotechnologies CorpS Sale−$1.16M
2021-03-01ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2021-03-01ADPTAdaptive Biotechnologies CorpM Exercise/Conversion+$131K
2021-03-01ADPTAdaptive Biotechnologies CorpS Sale−$1.16M
2021-03-01ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion—
2021-02-14ADPTAdaptive Biotechnologies CorpA Award—
2021-02-14ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)A Award—
2020-12-21ADPTAdaptive Biotechnologies CorpM Exercise/Conversion+$164K
2020-12-21ADPTAdaptive Biotechnologies CorpS Sale−$1.5M
2020-12-21ADPTAdaptive Biotechnologies Corp · Stock Option (Right to Buy)M Exercise/Conversion—

Recent filings

9